DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/779vqq/clinical_trial) has announced the addition of the "Clinical Trial Regulatory Guideline Requirements (London, UK - November 24-25, 2015)" conference to their offering.
Are you up to date with the regulatory requirements for clinical research in Europe? Do you understand the impact of the new EU Clinical Trials Regulation?
The EU Clinical Trials Regulation was finalized and published by the Official Journal of the EU in May 2014 and is due to come into force in 2016. This new regulation will replace the European Clinical Trials Directive (2001/20/EC). This course will provide an essential understanding to help with compliance for clinical trials, particularly carried out in the EU.
This course will take you through the key regulatory and guideline requirements for clinical research in Europe, including the new Clinical Trial Regulation and existing Directive requirements. Also the key US requirements which impact on trials being carried out in Europe will also be briefly covered.
Benefits of Attending:
Attending this course will help ensure you are familiar with the regulations for running clinical trials and with the recent developments. The course will highlight the most important of these key requirements and changes and how these are likely to impact on trials now and in the future for pharmaceutical, biotechnology companies and study sites.
The course will include a number of group discussions and opportunities for you to discuss issues relevant to your own trials. To maximize the discussions you will be provided with copies of the key guidelines and the new EU Clinical Trial Regulation to review.
This course provides an overview and refresher of the current clinical trail regulatory requirements and an update on the New Clinical Trial Regulation.
For more information visit http://www.researchandmarkets.com/research/779vqq/clinical_trial
